|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.15 CNY | -1.24% |
|
+1.61% | -4.29% |
| 04-16 | Gan & Lee Pharmaceuticals Gets Nod to Trial GLR1062 Injection | MT |
| 04-15 | Gan & Lee Pharmaceuticals' Subsidiary Doses First Subject for Phase III of GZR33 Injection Trial; Shares Up 3% | MT |
Quotes 5-day view: Gan & Lee Pharmaceuticals.
End-of-day quote Shanghai S.E.| 13/04/2026 | 14/04/2026 | 15/04/2026 | 16/04/2026 | 17/04/2026 | |
|---|---|---|---|---|---|
| Last | 63.52 ¥ | 64.29 ¥ | 65.96 ¥ | 65.97 ¥ | 65.15 ¥ |
| Volume | 3,962,183 | 5,067,182 | 11,400,710 | 6,239,058 | 5,611,489 |
| Change | -0.94% | +1.21% | +2.60% | +0.02% | -1.24% |
| Opening | 63.61 ¥ | 63.90 ¥ | 65.40 ¥ | 66.44 ¥ | 65.67 ¥ |
| High | 64.21 ¥ | 64.30 ¥ | 66.57 ¥ | 66.44 ¥ | 65.83 ¥ |
| Low | 63.36 ¥ | 63.00 ¥ | 64.50 ¥ | 65.31 ¥ | 64.35 ¥ |
Performance
| 1 day | -1.24% | ||
| 1 week | +1.61% | ||
| Current month | +1.80% | ||
| 1 month | +6.37% | ||
| 3 months | -9.74% | ||
| 6 months | -6.10% | ||
| Current year | -4.29% | ||
| 1 year | +50.74% | ||
| 3 years | +73.27% | ||
| 5 years | -48.65% |
Volumes
marketsDaily volume
5,611,489
Avg. Volume 20 sessions
7,433,521
Avg. Volume 20 sessions CNY
484,293,893.15
Avg. Volume 20 sessions USD
71,045,429.83
Record volume 1
42,967,290
Record volume 2
40,612,370
Record volume 3
36,646,360
Capital turnover ratio
0.01
Float rotation
0.02
Basic data
Capitalization (CNY)
38,777,413,428
Capitalization (USD)
5,688,423,393
Net sales (CNY)
3,045,347,810
Net sales (USD)
446,734,998
Number of employees
5,245
Sales / Employee (CNY)
580,619
Sales / Employee (USD)
85,173
Free-Float
50.32 %
Free-Float capitalization (CNY)
19,703,267,006
Free-Float capitalization (USD)
2,890,355,881
Average Daily Capital Traded
1.25%
Indicators
Moving average 5 days
64.98
Moving average 20 days
62.6
Moving average 50 days
63.89
Moving average 100 days
65.42
Price spread / (MMA5)
-0.26%
Price spread / (MMA20)
-3.91%
Price spread / (MMA50)
-1.93%
Price spread / (MMA100)
+0.41%
RSI 9 days
58.51
RSI 14 days
55.66
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.24% | +1.61% | +50.74% | +73.27% | 5.69B | |
| +0.61% | +0.23% | +33.28% | -7.21% | 77.02B | |
| -3.56% | -7.12% | +81.53% | +192.06% | 59.3B | |
| -0.93% | +60.10% | +60.10% | +60.10% | 50.73B | |
| +0.21% | +0.09% | -41.91% | -54.17% | 47.29B | |
| +0.76% | +2.53% | +49.52% | -39.32% | 26.03B | |
| -1.76% | +5.42% | +117.36% | -62.39% | 21.3B | |
| +2.62% | +1.82% | +68.05% | +32.53% | 19.47B | |
| -0.24% | +3.55% | +58.40% | +58.88% | 15.94B | |
| -0.98% | +2.90% | +126.60% | +360.13% | 14.88B | |
| Average | -0.41% | +1.69% | +60.37% | +61.39% | 33.77B | |
| Weighted average by Cap. | -0.55% | +0.61% | +49.41% | +48.32% |
Historical Quotes: Gan & Lee Pharmaceuticals.
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Course Extremes
| 1 week | 63 |  | 66.57 |
| 1 month | 55.8 | | 66.57 |
| Current year | 55.8 | | 74.47 |
| 1 year | 42.84 | | 82.25 |
| 3 years | 32.1 | | 82.25 |
| 5 years | 30.53 | | 138.5 |
| 10 years | 30.53 | | 204.41 |
Monthly variations
Annual variations
| 2026 | -4.29% | ||
| 2025 | +54.35% | ||
| 2024 | -16.24% | ||
| 2023 | +61.60% | ||
| 2022 | -53.68% | ||
| 2021 | -46.80% | ||
| 2020 | +103.01% |
- Stock Market
- Equities
- 603087 Stock
- Quotes Gan & Lee Pharmaceuticals.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition